Skip to main content
Year archive

Sphere Corp. — 2023 filings

All 67 regulatory filings released by Sphere Corp. (347700) in 2023, sourced directly from the official regulator.

67 Filings
2023 Period
2023 filings (67)
Filing Released Lang
[기재정정]영업양수결정(종속회사의주요경영사항)
M&A Activity
2023-12-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-12-22 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-12-22 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-12-22 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-12-22 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-12-22 Korean
전환사채(해외전환사채포함)발행후만기전사채취득(제2회차)
Capital/Financing Update
2023-12-21 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2023-12-15 Korean
전환가액의조정(제2회차)
Capital/Financing Update
2023-12-15 Korean
주권관련사채권의취득결정
Capital/Financing Update
2023-12-15 Korean
증권발행실적보고서
Capital/Financing Update
2023-12-14 Korean
[기재정정]증권발행실적보고서
Share Issue/Capital Change
2023-12-14 Korean
증권발행결과(자율공시)(주주배정 유상증자)
Share Issue/Capital Change
2023-12-14 Korean
유상증자또는주식관련사채등의청약결과(자율공시)
Share Issue/Capital Change
2023-12-13 Korean
유상증자또는주식관련사채등의청약결과(자율공시)
Capital/Financing Update
2023-12-08 Korean
유상증자최종발행가액확정
Capital/Financing Update
2023-12-04 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-12-04 Korean
[발행조건확정]증권신고서(지분증권)
Share Issue/Capital Change
2023-12-04 Korean
[기재정정]투자설명서
Capital/Financing Update
2023-12-04 Korean
[기재정정]투자설명서
Management Reports 9M 2023
2023-12-01 Korean
전환사채(해외전환사채포함)발행후만기전사채취득(제2회차)
Capital/Financing Update
2023-12-01 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-11-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-11-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-11-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-11-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-11-28 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-11-27 Korean
영업양수결정(종속회사의주요경영사항)
M&A Activity
2023-11-22 Korean
[기재정정]증권신고서(지분증권) (2023.12)
Regulatory Filings 9M 2023
2023-11-16 Korean
분기보고서 (2023.09)
Interim / Quarterly Report 9M 2023
2023-11-14 Korean
유상증자1차발행가액결정
Share Issue/Capital Change
2023-10-31 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-10-31 Korean
[발행조건확정]증권신고서(지분증권)
Capital/Financing Update
2023-10-31 Korean
투자설명서
Investor Presentation
2023-10-31 Korean
권리락(유상증자)
Share Issue/Capital Change
2023-10-31 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-10-16 Korean
[기재정정]증권신고서(지분증권) (2023.12)
Capital/Financing Update
2023-10-16 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings
2023-09-27 Korean
[기재정정]증권신고서(지분증권) (2023.11)
Capital/Financing Update
2023-09-25 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-09-11 Korean
증권신고서(지분증권) (2023.11)
Share Issue/Capital Change
2023-09-11 Korean
주권관련사채권의취득결정
Capital/Financing Update
2023-09-05 Korean
주권관련사채권의취득결정
Capital/Financing Update
2023-09-05 Korean
기타경영사항(자율공시)(호흡재활소프트웨어 '레드필 숨튼'의 국내 확증 임상시험 결과)
Regulatory Filings
2023-08-30 Korean
반기보고서 (2023.06)
Interim / Quarterly Report H1 2023
2023-08-29 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings
2023-06-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-06-07 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-06-07 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Q1 2023
2023-05-30 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-05-30 Korean
단일판매ㆍ공급계약체결
Regulatory Filings
2023-05-26 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2023-05-15 Korean
타법인주식및출자증권취득결정(자율공시)
M&A Activity
2023-05-12 Korean
주주총회소집결의
AGM Information
2023-04-19 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2023-04-19 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2023-04-03 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-03-31 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings
2023-03-31 Korean
감사보고서제출
Audit Report / Information FY 2022
2023-03-23 Korean
사업보고서 (2022.12)
Annual Report FY 2022
2023-03-23 Korean
주주총회집중일개최사유신고
AGM Information
2023-03-16 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2023-03-16 Korean
주주총회소집결의
AGM Information
2023-03-13 Korean
타법인주식및출자증권취득결정
M&A Activity
2023-03-13 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2022
2023-02-16 Korean
기타경영사항(자율공시)('시계열 검진 데이터를 이용한 딥러닝 기반 전립선암 재발예측 시스템' 특허권 취득)
Regulatory Filings
2023-02-10 Korean
기타경영사항(자율공시)('예측 데이터를 이용한 전립선암 치료 계획 시스템' 특허권 취득)
Regulatory Filings
2023-02-01 Korean